References
- Sheldrick, G.M.; Jones, P.G.; Kennard, O.; Williams, D.H.; Smith, G.A. Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine. Nature 1978, 271, 223–225.
- Nicolaou, K.C.; Boddy, C.N.C.; Bräse, S.; Winssinger, N. Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew. Chem. Int. Ed. 1999, 38, 2096–2152.
- Kahne, D.; Leimkuhler, C.; Lu, W.; Walsh, C. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 2005, 105, 425–448.
- Kern, T.; Giffard, M.; Hediger, S.; Amoroso, A.; Giustini, C.; Bui, N.K.; Joris, B.; Bougault, C.; Vollmer, W.; Simorre, J.-P. Dynamics characterization of fully hydrated bacterial cell walls by solid-state NMR: evidence for cooperative binding of metal ions. J. Am. Chem. Soc. 2010, 132, 10911–10919.
- Vollmer, W.; Seligman, S.J. Architecture of peptidoglycan: more data and more models. Trends Microbiol. 2010, 18, 59–66.
- Cabeen, M.T.; Jacobs-Wagner, C. Bacterial cell shape. Nat. Rev. Microbiol. 2005, 3, 601–610.
- Uttley, A.H.; Collins, C.H.; Naidoo, J.; George, R.C. Vancomycin-resistant enterococci. Lancet 1988, 1, 57–58.
- Reynolds, P.E.; Courvalin, P. Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob. Agents Chemother. 2004, 49, 21–25.
- Perichon, B.; Courvalin, P. VanA-type vancomycin-resistant staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53, 4580–4587.
- Loll, P.J.; Axelsen, P.H. The structural biology of molecular recognition by vancomycin. Annu. Rev. Biophys. Biomol. Struct. 2000, 29, 265–289.
- Ślusarz, R.; Ślusarz, M.J.; Samaszko, J.; Madaj, J. Conformational changes of peptidoglycan fragments during their interactions with vancomycin. Cent. Eur. J. Chem. 2011, 9, 422–431.
- Eliopoulos, G.M. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J. Infect. 2009, 59 (Suppl 1), S17–S24.
- Culos, K.A.; Cannon, J.P.; Grim, S.A. Alternative agents to vancomycin for the treatment of methicillin-resistant staphylococcus aureus infections. Am. J. Ther. 2011, 20, 200–212.
- Chang, M.H.; Kish, T.D.; Fung, H.B. Telavancin: a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults. Clin. Ther. 2010, 32, 2160–2185.
- Case, D.A.; Darden, T.A.; Cheatham, III, T.E.; Simmerling, C.L.; Wang, J.; Duke, R.E.; Luo, R.; Walker, R.C.; Zhang, W.; Merz, K.M.; et al. AMBER 12. University of California: San Francisco, 2012.
- Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M.C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 2003, 24, 1999–2012.
- Kirschner, K.N.; Yongye, A.B.; Tschampel, S.M.; González-Outeiriño, J.; Daniels, C.R.; Foley, B.L.; Woods, R.J. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 2008, 29, 622–655.
- Cieplak, P.; Cornell, W.D.; Bayly, C.; Kollman, P.A. Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins. J. Comput. Chem. 1995, 16, 1357–1377.
- Snowden, M.A.; Perkins, H.R. Peptidoglycan cross-linking in Staphylococcus aureus. An apparent random polymerisation process. Eur. J. Biochem. 1990, 191, 373–377.
- Van Dam, V.; Olrichs, N.; Breukink, E. Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies. Chembiochem 2009, 10, 617–624.
- Williams, D.H.; Bardsley, B. The vancomycin group of antibiotics and the fight against resistant Bacteria. Angew. Chem. Int. Ed. 1999, 38, 1172–1193.
- Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.D.; Impey, R.W.; Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926.
- Nitanai, Y.; Kikuchi, T.; Kakoi, K.; Hanamaki, S.; Fujisawa, I.; Aoki, K. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs. J. Mol. Biol. 2009, 385, 1422–1432.
- Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H.J.C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 1977, 23, 327–341.
- Berendsen, H.J.C.; Postma, J.P.M.; Gunsteren, W.F. van; DiNola, A.; Haak, J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684–3690.
- Ewald, P.P. Die Berechnung optischer und elektrostatischer Gitterpotentiale. Ann. Phys. 1921, 369, 253–287.
- Darden, T.; Perera, L.; Li, L.; Pedersen, L. New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure 1999, 7, R55–R60.
- Salomon-Ferrer, R.; Götz, A.W.; Poole, D.; Le Grand, S.; Walker, R.C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J. Chem. Theory Comput. 2013, 9, 3878–3888.
- Kollman, P.A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 2000, 33, 889–897.
- Reyes, C.M.; Kollman, P.A. Structure and thermodynamics of RNA-protein binding: using molecular dynamics and free energy analyses to calculate the free energies of binding and conformational change. J. Mol. Biol. 2000, 297, 1145–1158.
- Jayaram, B.; Sprous, D.; Beveridge, D.L. Solvation free energy of biomacromolecules: parameters for a modified generalized born model consistent with the AMBER force field. J. Phys. Chem. B 1998, 102, 9571–9576.
- De Paris, R.; Quevedo, C.V.; Ruiz, D.D.; Norberto de Souza, O.; Barros, R.C. Clustering molecular dynamics trajectories for optimizing docking experiments. Comput. Intell. Neurosci. 2015, 2015:916240, 1–9.
- Mackay, J.P.; Gerhard, U.; Beauregard, D.A.; Williams, D.H.; Westwell, M.S.; Searle, M.S. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J. Am. Chem. Soc. 1994, 116, 4581–4590.
- Sharman, G.J.; Try, A.C.; Dancer, R.J.; Cho, Y.R.; Staroske, T.; Bardsley, B.; Maguire, A.J.; Cooper, M.A.; O'Brie, D.P.; Williams, D.H. The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria. J. Am. Chem. Soc. 1997, 119, 12041–12047.
- Jia, Z.; O'Mara, M.L.; Zuegg, J.; Cooper, M.A.; Mark, A.E. Vancomycin: ligand recognition, dimerization and super-complex formation. FEBS J. 2013, 280, 1294–1307.
- Treviño, J.; Bayón, C.; Ardá, A.; Marinelli, F.; Gandolfi, R.; Molinari, F.; Jimenez-Barbero, J.; Hernáiz, M.J. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy. Chemistry 2014, 20, 7363–7372.
- Münch, D.; Engels, I.; Müller, A.; Reder-Christ, K.; Falkenstein-Paul, H.; Bierbaum, G.; Grein, F.; Bendas, G.; Sahl, H.-G.; Schneider, T. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin. Antimicrob Agents Chemother. 2014, 59, 772–781.